BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24578620)

  • 1. Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies.
    Brondino N; Re S; Boldrini A; Cuccomarino A; Lanati N; Barale F; Politi P
    ScientificWorldJournal; 2014; 2014():174282. PubMed ID: 24578620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized curcumin formulations for the treatment of Alzheimer's disease: A patent evaluation.
    Shakeri A; Sahebkar A
    J Neurosci Res; 2016 Feb; 94(2):111-3. PubMed ID: 26577706
    [No Abstract]   [Full Text] [Related]  

  • 3. Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule?
    Serafini MM; Catanzaro M; Rosini M; Racchi M; Lanni C
    Pharmacol Res; 2017 Oct; 124():146-155. PubMed ID: 28811228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges associated with curcumin therapy in Alzheimer disease.
    Belkacemi A; Doggui S; Dao L; Ramassamy C
    Expert Rev Mol Med; 2011 Nov; 13():e34. PubMed ID: 22051121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential role of the curry spice curcumin in Alzheimer's disease.
    Ringman JM; Frautschy SA; Cole GM; Masterman DL; Cummings JL
    Curr Alzheimer Res; 2005 Apr; 2(2):131-6. PubMed ID: 15974909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin and curcumin-like molecules: from spice to drugs.
    Marchiani A; Rozzo C; Fadda A; Delogu G; Ruzza P
    Curr Med Chem; 2014; 21(2):204-22. PubMed ID: 23590716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Mechanisms of Action of Curcumin in Alzheimer's Disease.
    Tang M; Taghibiglou C
    J Alzheimers Dis; 2017; 58(4):1003-1016. PubMed ID: 28527218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis.
    Zhu LN; Mei X; Zhang ZG; Xie YP; Lang F
    Phytother Res; 2019 Mar; 33(3):524-533. PubMed ID: 30575152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REVIEW: Curcumin and Alzheimer's disease.
    Hamaguchi T; Ono K; Yamada M
    CNS Neurosci Ther; 2010 Oct; 16(5):285-97. PubMed ID: 20406252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenylated Curcumin Analogues as Multipotent Tools To Tackle Alzheimer's Disease.
    Bisceglia F; Seghetti F; Serra M; Zusso M; Gervasoni S; Verga L; Vistoli G; Lanni C; Catanzaro M; De Lorenzi E; Belluti F
    ACS Chem Neurosci; 2019 Mar; 10(3):1420-1433. PubMed ID: 30556996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of curcumin and its modified formulations on Alzheimer's disease.
    Farkhondeh T; Samarghandian S; Pourbagher-Shahri AM; Sedaghat M
    J Cell Physiol; 2019 Aug; 234(10):16953-16965. PubMed ID: 30847942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in clinical study of curcumin.
    Yang C; Su X; Liu A; Zhang L; Yu A; Xi Y; Zhai G
    Curr Pharm Des; 2013; 19(11):1966-73. PubMed ID: 23116307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective.
    Apetz N; Munch G; Govindaraghavan S; Gyengesi E
    CNS Neurol Disord Drug Targets; 2014; 13(7):1175-91. PubMed ID: 25230232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?
    Zholos AV; Moroz OF; Storozhuk MV
    Curr Mol Pharmacol; 2019; 12(1):12-26. PubMed ID: 30318014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of Curcumin in Depression: A Meta-Analysis.
    Ng QX; Koh SSH; Chan HW; Ho CYX
    J Am Med Dir Assoc; 2017 Jun; 18(6):503-508. PubMed ID: 28236605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of TNF-α Inhibition for Alzheimer's Disease Prevention.
    Torres-Acosta N; O'Keefe JH; O'Keefe EL; Isaacson R; Small G
    J Alzheimers Dis; 2020; 78(2):619-626. PubMed ID: 33016914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer's Disease.
    ELBini-Dhouib I; Doghri R; Ellefi A; Degrach I; Srairi-Abid N; Gati A
    Molecules; 2021 May; 26(10):. PubMed ID: 34070220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.